Abstract
AbstractThe use of miconazole nitrate (MN) in the treatment of oropharyngeal candidiasis (OPC) is limited by low drug bioavailability, frequent administration, fungal resistance and toxicity concerns. Lipid nanogel comprising solid lipid nanoparticles (SLNs) incorporated into a gel base could be employed to prolong and target MN to the oromucosal layers, minimizing its associated side effects while enhancing its lethality against resistant
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.